Picture of Zeria Pharmaceutical logo

4559 — Zeria Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMid CapNeutral

Table: Zeria Pharm -Q1 group results

Aug 4 (Reuters)- 
             Zeria Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2020        Jun 30, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             13.33               15.11            61.00    
                 (-11.8 pct)         (-1.0 pct)       (+0.9 pct)  
  Operating          1.06                1.33             4.30    
                 (-20.3 pct)         (-18.6 pct)      (+5.0 pct)  
  Recurring        634 mln               1.56             3.90    
                 (-59.3 pct)         (-10.6 pct)      (+0.5 pct)  
  Net              974 mln               1.15             3.30    
                 (-15.0 pct)         (-48.9 pct)      (+12.8 pct) 
  EPS             21.05 yen           24.14 yen        71.47 yen  
  Ann Div                             34.00 yen        34.00 yen  
  -Q2 div                             17.00 yen        17.00 yen  
  -Q4 div                             17.00 yen        17.00 yen  
  
  NOTE - Zeria Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T

Recent news on Zeria Pharmaceutical

See all news